Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis

Stock Information for Biodesix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biodesix Inc.

Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
Biodesix to Participate in Upcoming Investor Conferences
Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings
Biodesix Announces Third Quarter 2025 Results and Highlights
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital(TM) PCR High Complexity Assays

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.